When Lung Cancer Spreads to Your Lymph Nodes: What to Expect

When Lung Cancer Spreads to Your Lymph Nodes: What to Expect

When Lung Cancer Spreads to Your Lymph Nodes: What to Expect
iStock (2); Everyday Health
Lung cancer starts in the lungs, but sometimes cancer cells escape and travel to nearby lymph nodes. Once cancer enters the lymphatic system, it can spread to distant organs and tissues.

 The medical term for cancer that has spread is "metastasis."
Knowing whether lung cancer is in lymph nodes, and which lymph nodes it has spread to, helps doctors assign the cancer a stage and determine which treatments to use.

While surgery may still be an option once there is lung cancer metastasis to lymph nodes, body-wide treatments like chemotherapy or immunotherapy are often added to it.

 Lung cancer that's in lymph nodes outside the lung generally has a lower survival rate than cancer that is only in the lung, but treatments can still be effective against it.

Lymph Node Metastasis

Lymph nodes are an important part of the immune system. These bean-shaped structures filter out unwanted substances, including germs like bacteria and viruses, damaged cells, and cancer cells.

"Lymph nodes are like the garbage cans of the body," explains Richard Anderson, MD, a thoracic surgeon with OSF HealthCare in Peoria, Illinois.
All of the "garbage" that ends up in the lymph nodes travels (along with lymph fluid) through the network of lymph vessels throughout the body. The lymph nodes and vessels are known collectively as the lymphatic system. Cancer cells that break off from the tumor in the lung can squeeze through lymph vessel walls into the lymphatic system. From there, they can reach lymph nodes.

The first lymph nodes that lung cancer cells usually spread to are ones closest to the lungs, but cancer can also travel to nodes farther away. "Knowing exactly which lymph nodes are affected helps doctors figure out the stage of the cancer and decide on the best treatment," says Tingting Tan, MD, PhD, a medical oncologist and hematologist at City of Hope in Newport Beach, California.

Lung Cancer Staging

Doctors assign lung cancer a stage based on the size of the tumor, whether cancer cells are in the lymph nodes, how many nodes contain cancer, and whether the cancer has spread to distant sites like the bones, brain, or adrenal glands, says Dr. Anderson.

Non-Small Cell Lung Cancer (NSCLC) Staging

Non-small cell lung cancer (NSCLC), the most common type of lung cancer, is assigned a stage number from 0 to 4. The higher the number, the farther the cancer has spread.

  • Stage 0 Cancer cells are only in the layers of the lung and it hasn't spread to any other parts of the lung or to lymph nodes.
  • Stage 1 The cancer is larger. It has invaded other parts of the lung, but it has not spread to lymph nodes.
  • Stage 2 The tumor is larger than stage 1 and it may have spread to nearby lymph nodes.
  • Stage 3 Cancer is in the lymph nodes, possibly including nodes in the mediastinum (the area between the lungs).
  • Stage 4 The cancer has spread to distant lymph nodes and organs.

Small Cell Lung Cancer (SCLC) Staging

Small cell lung cancer (SCLC) has only two stages:

  • Limited stage: The cancer is on one side of the chest. It may be in lymph nodes on the same side of the chest as the tumor.
  • Extensive stage: Cancer has spread through one lung, to the other lung, or to other parts of the body.

Lymph Node Classifications

The staging system takes into account not only whether lung cancer metastasis to lymph nodes has happened, but also which nodes the cancer is in. Ipsilateral means the affected nodes are on the same side of the body as the cancer. Contralateral means they are on the opposite side of the body from the cancer.

These are the lymph nodes where lung cancer can travel:

  • Peribronchial lymph nodes are near the air passages — bronchi — of the lungs.
  • Hilar lymph nodes are in the hilum — the area where the airways, blood vessels, and nerves enter the lungs.
  • Pulmonary lymph nodes are in the lung.
  • Mediastinal lymph nodes are in the mediastinum — the space between the lungs.
  • Subcarinal lymph nodes are in the area where the windpipe splits into the right and left lung airways.
  • Supraclavicular nodes are above the collarbone.

TNM Staging

The American Joint Committee on Cancer (AJCC) TNM system further classifies lung cancers based on these three factors:

  • T: How large is the tumor and has it grown into nearby structures or organs?
  • N: Has the cancer spread to lymph nodes, and if so, which ones?
  • M: Has the cancer metastasized, or spread to distant organs like the brain, bones, or adrenal glands?
The N is staged from 0 to 3. The higher the number, the more lymph nodes cancer has spread to:

  • N0: There is no cancer in the lymph nodes.
  • N1: There is cancer in the pulmonary or hilar lymph nodes on the same side of the body as the cancer.
  • N2: There is cancer in the mediastinal lymph nodes on the same side of the body as the cancer, or in the subcarinal nodes.
  • N3: There is cancer in the mediastinal, hilar, or supraclavicular nodes on the opposite side of the body as the cancer.

Symptoms of Lung Cancer Metastasis to Lymph Nodes

Metastatic lung cancer causes general lung cancer symptoms, as well as symptoms that are specific to lymph node spread. Lung cancer symptoms include:

  • A constant cough
  • Coughing up blood
  • Shortness of breath
  • A hoarse voice
  • Appetite loss
  • Unexplained weight loss
  • Repeated lung infections
  • Tiredness and weakness
If cancer is in the lymph nodes, they may feel swollen. They'll feel like lumps in the neck or under the arm. Because swollen lymph nodes are also a sign of an infection, it's important to see a doctor for tests to confirm the cause.

Diagnosing Lymph Node Metastasis

Imaging tests can show whether lung cancer has spread, and if so, how far it has spread:

  • Computed Tomography (CT) Scan A CT scan takes multiple X-ray images from different angles, and then a computer combines the pictures to create a very detailed cross-sectional picture of the suspected area. This test can show enlargement that might be cancer in a lymph node.
  • Positron Emission Tomography (PET) Scan A PET scan uses radioactive sugar to find areas of cancer in lymph nodes or distant sites. Cancer cells take in more sugar than healthy tissue, which makes them "light" up on the scan.

The only way to confirm the diagnosis is with a biopsy. "This might involve removing a lymph node surgically or using a needle to collect tissue samples," says Dr. Tan. The doctor can guide the needle with a camera placed in the airway, which is called an endobronchial ultrasound (EBUS). A lab then tests the biopsy samples for cancer.

In addition to EBUS, your doctor might use other imaging methods during biopsy, depending on the location of the lymph nodes from which they wish to take a sample. For example, a mediastinoscopy uses a lighted tube to look in the area between the lungs, from which a tissue sample can be taken.

Treatment Options for Lung Cancer With Lymph Node Metastasis

Once cancer has spread to the lymph nodes, a more systemic (body-wide) treatment may be needed. "The [treatment] plan depends on how much the cancer has spread and what the patient prefers," says Tan.

Treatment options include one or more of these therapies:

  • Surgery Depending on the extent of the cancer, surgery could involve removing part of a lobe, an entire lobe, or a whole lung.

     The surgeon will take out the tumor, some surrounding tissue, and any lymph nodes that are suspected or known to contain cancer.

  • Chemotherapy This treatment uses powerful medicines to kill cancer cells all over the body. It's often part of the treatment for lung cancer that has spread to lymph nodes, sometimes in combination with surgery or radiation therapy. Chemotherapy for lung cancer is typically delivered into a vein.

  • Radiation Therapy It uses high-energy X-rays to damage the DNA inside cancer cells and stop the cells from dividing. Radiation therapy is often part of the treatment when lung cancer has spread to the lymph nodes, sometimes along with chemotherapy or immunotherapy. The radiation is delivered externally from a machine, or internally from pellets or other radioactive objects placed inside the body near the tumor.

  • Targeted Therapy These medicines block proteins or other substances that help lung cancer grow. Targeted therapy is a treatment for lung cancers with certain gene mutations, such as KRAS, EGFR, or ALK.

  • Immunotherapy This treatment helps the immune system more effectively fight the cancer. Immune checkpoint inhibitors are a type of immunotherapy used to treat lung cancer. These drugs act on cellular “switches” that turn on or off cancer-fighting immune cells to launch an attack.

Prognosis and Outlook

Once cancer escapes the lung and gets into the lymph nodes, it can affect the prognosis. The outlook depends on how far the cancer has spread and how well it responds to treatment.

When the cancer has spread outside of the lung to the lymph nodes, the five-year relative survival rate is 37 percent for NSCLC and 18 percent for SCLC.

 Once the cancer spreads to distant organs, the five-year survival rate is 9 percent for NSCLC and 3 percent for SCLC.

These numbers don't tell the whole story, though. Each person with lung cancer is unique, and general statistics may not reflect your outcome. Treatment technology is evolving, and these statistics are from large groups of people who were diagnosed and treated five years ago or more. It's possible that today's outlook for lung cancer metastasized to the lymph nodes could be better than in the past.

"While lung cancer with lymph node involvement is more advanced than cancer confined to the lung, individualized treatment approaches can help patients achieve meaningful disease control and maintain quality of life," says Tan.

The Takeaway

  • Lung cancer can spread from the lungs to nearby lymph nodes, or to nodes in the neck or belly.
  • Cancer in the lymph nodes affects staging and treatment.
  • Treatment options for lung cancer in the lymph nodes include surgery, radiation therapy, chemotherapy, immunotherapy, and targeted therapy.
  • The prognosis depends on how far the cancer has spread, and whether it's in distant organs.

Resources We Trust

EDITORIAL SOURCES
Everyday Health follows strict sourcing guidelines to ensure the accuracy of its content, outlined in our editorial policy. We use only trustworthy sources, including peer-reviewed studies, board-certified medical experts, patients with lived experience, and information from top institutions.
Resources
  1. Where Does Metastatic Lung Cancer Spread To? Moffitt Cancer Center.
  2. Non-Small Cell Lung Cancer Stages. American Cancer Society. January 29, 2024.
  3. Treatment Choices for Non-Small Cell Lung Cancer, by Stage. American Cancer Society. October 29, 2024.
  4. Lung Cancer Survival Rates. American Cancer Society. January 29, 2024.
  5. Lymph Nodes. Cleveland Clinic. March 19, 2025.
  6. Lymph Nodes and Cancer. American Cancer Society. August 25, 2023.
  7. Non-Small Cell Lung Cancer Stages. American Cancer Society. January 29, 2024.
  8. Small Cell Lung Cancer Stages. American Cancer Society. January 29, 2024.
  9. Detterbeck FD. The Eighth Edition TNM Stage Classification for Lung Cancer: What Does It Mean on Main Street? The Journal of Thoracic and Cardiovascular Surgery. January 2018.
  10. Symptoms of metastatic Lung Cancer. Cancer Research UK. March 21, 2023.
  11. Symptoms of Metastatic Lung Cancer. Cancer Research UK. January 29, 2024.
  12. Tests for Lung Cancer. American Cancer Society. March 21, 2023.
  13. Surgery for Non-Small Cell Lung Cancer. American Cancer Society. January 29, 2024.
  14. Lung Cancer Surgery. American Lung Association. September 26, 2024.
  15. Chemotherapy for Non-Small Cell Lung Cancer. American Cancer Society. January 29, 2024.
  16. Radiation Therapy for Lung Cancer. City of Hope. January 24, 2025.
  17. Targeted Drug Therapy for Non-Small Cell Lung Cancer. American Cancer Society. May 16, 2025.
  18. Immunotherapy for Non-Small Cell Lung Cancer. American Cancer Society. March 13, 2025.
nimit-sudan-bio

Nimit Sudan, MD

Medical Reviewer

Nimit Sudan, MD, is a hematologist and medical oncologist with UCLA. He is an assistant clinical professor at UCLA and serves as a lead physician at the Encino community practice. He has a special interest in integrative medicine and oncology.

Dr. Sudan provides comprehensive care for adult patients with all types of hematologic and oncologic conditions. His mission is to treat every patient with the utmost compassion and care, and to develop a strong doctor-patient relationship. He is passionate about patient and family education, and educating larger communities on cancer awareness and prevention. He also has a special interest in integrative medicine, and is certified in acupuncture.

Sudan is from the Midwest, and received both his medical degree and bachelor's degree from Wayne State University in Detroit, Michigan. He completed his internal medicine residency at the Cleveland Clinic Foundation, and his hematology/oncology fellowship at Western Pennsylvania Hospital in Pittsburgh.

stephanie-watson-bio

Stephanie Watson

Author
Stephanie Watson is a freelance health writer who has contributed to WebMD, AARP.org, BabyCenter, Forbes Health, Fortune Well, Time, Self, Arthritis Today, Greatist, Healthgrades, and HealthCentral. Previously, she was the executive editor of Harvard Women’s Health Watch and Mount Sinai’s Focus on Healthy Aging. She has also written more than 30 young adult books on subjects ranging from celebrity biographies to brain injuries in football.